AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Purple Biotech Ltd.

Prospectus Dec 28, 2019

7004_rns_2019-12-28_a45e0967-d005-4e13-a83e-40d979c78d31.htm

Prospectus

Open in Viewer

Opens in native device viewer

_________ false

����� ����� ��"� 2 352
KITOV PHARMA LTD
Corporation no: 520031238 10994
- - -
Israel Securities Authority Tel Aviv Stock Exchange C004 ( Public ) Reported via MAGNA: 28/12/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-114513 Time of broadcast: 19:12 19:11:14

Immediate report on other matterDon't use this form if there is more adequate one

Filed pursuant to Rule 424(b)(3) Registration No. 333-233793 Prospectus Supplement No. 2 (To Prospectus dated September 16, 2019) ����� ������ ������ �� ������ ����� ���� 2 ������ �� ����� ����"� ���� ���� ������ ������ ����� �� ������ ���� �� ����� ��� ����� ���� ������ ������. ��� �� ���� ����� ���� �� ����� ����� ����� ������ ������ ���� �� ������ ������ ���� �� �����, ��� ����� ����� �� ����� ������ ���� ��� ����� �� ���� �����, �� �� ����, ����� �� ����� ���� ����� ����� ���� ����� ���� ������ �� ���� �������� ����� ����� ������ ��� ��� ����� �� ���� �����
Attached file f424b3122319_kitovpharmaEDGAR3_Bannerless_isa.pdf
The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a Prospectus Supplement originally filed by the Company with the United States Securities Exchange Commission under the Securities Act of 1933 should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2019-02-085068     2019-02-096835     2019-02-085128
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 17/12/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: ABZ Law Office
Address: Yad Harutzim 15 , Jerusalem 9342152 Telephone: 079-5722070 Facsimile: 079-5722206 E-mail: [email protected] 1
Israel

Talk to a Data Expert

Have a question? We'll get back to you promptly.